Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.

Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO.

Contraception. 2013 Jan;87(1):93-100. doi: 10.1016/j.contraception.2012.09.015. Epub 2012 Oct 19.

PMID:
23083525
2.

Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.

Tepper NK, Dragoman MV, Gaffield ME, Curtis KM.

Contraception. 2017 Feb;95(2):130-139. doi: 10.1016/j.contraception.2016.10.005. Epub 2016 Oct 19. Review.

PMID:
27771476
3.

Estrogen and progestin components of oral contraceptives: relationship to vascular disease.

Carr BR, Ory H.

Contraception. 1997 May;55(5):267-72. Review.

PMID:
9220222
4.

Combined hormonal contraception and venous thromboembolism.

Martínez F, Avecilla A.

Eur J Contracept Reprod Health Care. 2007 Jun;12(2):97-106. Review.

PMID:
17559006
5.

Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.

Dragoman M, Curtis KM, Gaffield ME.

Contraception. 2016 Sep;94(3):280-7. doi: 10.1016/j.contraception.2015.08.002. Epub 2015 Aug 10. Review.

6.

[Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].

Botzenhardt S, Toni I, Rascher W, Neubert A.

Klin Padiatr. 2013 Sep;225(5):268-76. doi: 10.1055/s-0033-1351288. Epub 2013 Aug 26. Review. German.

PMID:
23979828
7.

Thrombotic risks of oral contraceptives.

Rott H.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):235-40. doi: 10.1097/GCO.0b013e328355871d. Review.

PMID:
22729096
8.

Hormonal contraception and venous thromboembolism.

Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE.

Acta Obstet Gynecol Scand. 2012 Jul;91(7):769-78. doi: 10.1111/j.1600-0412.2012.01444.x. Review.

PMID:
22568831
9.

Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.

Sehovic N, Smith KP.

Ann Pharmacother. 2010 May;44(5):898-903. doi: 10.1345/aph.1M649. Epub 2010 Apr 6. Review.

PMID:
20371756
10.

Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.

Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ.

BJOG. 2013 Jun;120(7):801-10. doi: 10.1111/1471-0528.12210. Epub 2013 Mar 26. Review.

11.

Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.

Martínez F, Ramírez I, Pérez-Campos E, Latorre K, Lete I.

Eur J Contracept Reprod Health Care. 2012 Feb;17(1):7-29. doi: 10.3109/13625187.2011.643836. Review.

PMID:
22239262
12.

Thrombotic diseases in young women and the influence of oral contraceptives.

Lidegaard O.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 2):S62-7. Review.

PMID:
9753312
13.

Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.

Horton LG, Simmons KB, Curtis KM.

Contraception. 2016 Dec;94(6):590-604. doi: 10.1016/j.contraception.2016.05.014. Epub 2016 Jun 1. Review.

PMID:
27263039
14.

Modern oral contraceptives and cardiovascular disease.

Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.

Am J Obstet Gynecol. 1997 Sep;177(3):707-15. Review.

PMID:
9322646
15.

Contraception-related venous thromboembolism in adolescents.

O'Brien SH.

Semin Thromb Hemost. 2014 Feb;40(1):66-71. doi: 10.1055/s-0033-1363469. Epub 2013 Dec 19. Review.

PMID:
24356931
16.

Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports.

Toni I, Neubert A, Botzenhardt S, Gratzki N, Rascher W.

Klin Padiatr. 2013 Sep;225(5):266-7. doi: 10.1055/s-0033-1353169. Epub 2013 Aug 23. Review. No abstract available.

PMID:
23975850
17.

Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?

Lewis MA.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 2):S68-77. Review.

PMID:
9753313
18.

Hormonal contraceptives and venous thromboembolism: an epidemiological update.

Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M.

Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):25-34. doi: 10.1016/j.beem.2012.11.002. Epub 2012 Dec 21. Review.

PMID:
23384743
19.

A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.

Lippman JS, Shangold GA.

Int J Fertil Womens Med. 1997 Jul-Aug;42(4):230-9. Review. No abstract available.

PMID:
9309456
20.

Oral contraceptives and venous thromboembolism: an epidemiological review.

Lidegaard O.

Eur J Contracept Reprod Health Care. 1996 Mar-May;1(1):13-20. Review.

PMID:
9678133

Supplemental Content

Support Center